[Sigbioinform-l] Sam Jaffee "Enter the Heavyweights" The Scientist 16[13]:44, Jun. 24, 2002
Garfield, Eugene
Garfield at codex.cis.upenn.edu
Tue Jun 25 11:48:51 EDT 2002
http://www.the-scientist.com/yr2002/jun/prof2_020624.html
The Scientist 16[13]:44, Jun. 24, 2002
The Scientist 16[13]:44, Jun. 24, 2002
PROFESSION
Enter the Heavyweights
The world's largest computer companies climb into the
bioinformatics ring
By Sam Jaffe
When Sun Microsystems and IBM announced
plans to target bioinformatics as a key
strategic
market, they sent shivers through the small
club
of bioinformaticians. So far, no one company
dominates the market, which consists of
dozens of small biotechs with competing
products and platforms. Would the arrival of
the
great whites mean the end of the guppies?
The answer to that question has so far been
a resounding no. Instead, the big computer
companies might make it easier to work in
bioinformatics, rather than dominating the
market with deep pockets and massive sales
forces. Bioinformatics started out as the
domain
of a few computer nerds within pharmaceutical
companies and university campuses. Today, it
is an industry that employs thousands and
creates billions of dollars of revenue. Five
years
from now, according to the technology
consultancy, International Data Corporation
(IDC), it should be a $38 billion (US)
industry.
That kind of growth has attracted attention in
these times of economic sluggishness.
SmartMoney magazine recently listed
bioinformatician as one of the five best jobs
for
recent graduates. Several universities are now
offering bioinformatics degree programs.
Fears that diversity and competition will end with the emergence of
Sun, IBM, and
Hewlett-Packard, the world's three largest computer companies, have
proven to be
unfounded. Indeed, thanks to changes in the computer industry, most of
the
heavyweights (with Microsoft being the main exception) stress open
standards and, in
some areas, open-sourced software. As a result, the giants' arrival
could increase
market transparency and uniformity.
That uniformity in turn will make the process of becoming a
bioinformatician easier
(obviating the need to learn about competing technology platforms in
order to master
the basics) and potentially more rewarding. "These guys are the plumbers
of this
industry," says Debra Goldfarb, an analyst with IDC. "Once all the
plumbing starts to
work together, everyone else's job will become much more important."
Software Snarl
Currently, bioinformatics covers a jumble of competing technology
platforms that
cannot communicate with each other. The market is awash with dozens of
bioinformatics startups, and each hopes to become the industry standard
despite the
absence of the financial weight required to dominate. Enter the big
three.
Of the three, IBM has probably invested more in the sector and grown
more quickly
than its competitors. Jeff Augen, the worldwide director of business
strategy for IBM's
life sciences department, says his unit employs more than 500 people,
and hundreds
more throughout the company are indirectly supported by its sales. "And
we're hiring
as fast as we can," he says. Most of the jobs available are on the
science side, as the
information technology and sales jobs can be filled mainly internally.
"We want to hire
the best in the field," Augen says.
Although the company makes most of its sales from software, hardware,
and
services, it has also embarked on an ambitious project to do original
bioinformatics
research. Its Computational Biology Center in Yorktown Heights, NY,
employs more
than 80 people, many of them with PhDs in life science. The center will
soon have
sole use of the world's largest and fastest computer, dubbed Blue Gene
by IBM.
Sun Microsystems is not out to match IBM's flashy research center, but
its life
sciences division employs almost as many employees. Sun's biggest focus
is
providing hardware, and sales rose between 30% and 40% last year,
according to Sia
Zadeh, group manager for Sun's life sciences. "We're heading towards a
multibillion
dollar revenue base in the next couple of years," Zadeh says. The third
company
heavily invested in life sciences is Hewlett-Packard, thanks mainly to
its recent
acquisition of Compaq, which had made life sciences a priority. No one
at
Hewlett-Packard could comment for this article.
Open Data
Though these companies have a vested interest in selling proprietary
systems, they
support common standards in the life-sciences community. Sun, for
instance, is a
primary mover behind the newly formed Interoperable Informatics
Infrastructure
Consortium (I3C), whose goal is to establish common protocols and
interoperable
technologies for data exchange and knowledge management for the
life-sciences
community.
IBM, which also belongs to I3C, has focused on Linux, the open-source
operating
system software that allows programmers to see the source code and make
changes
to it as well. The source code to Microsoft's Windows operating system,
by
comparison, is encrypted, and any attempt to change it could land one in
jail. "We sell
more Linux systems than anything else," says Augen, despite IBM's own
closed-source operating system called AIX that it can sell, whereas
Linux is free.
"That's what everyone wants."
Still, not everyone is pleased with the big companies' efforts in
open-source
software. "Sun and IBM people can be found at standards meetings and
interoperability efforts, but I don't see many of them actively
contributing to biospecific
open-source efforts," says Craig Dagdigian, an independent consultant
and
open-source programmer. Nevertheless, even though he often competes with
the big
companies, he admits they have been more beneficial than harmful for the
industry.
I3C standards and operating systems like Linux will have tremendous
significance
as the industry matures. "Right now, nobody can talk to anyone else,"
says J.W.
Bizzarro, the founder of Bioinformatics.org, a nonprofit group that
hosts several
open-source projects. "We're at a point where the big guys like Sun and
IBM can have
a hugely positive impact by laying the pavement so that we're all
traveling on the same
road."
Sam Jaffe (sam.jaffe at verizon.net) is a freelance writer
in Philadelphia.
The Scientist 16[13]:44, Jun. 24, 2002
© Copyright 2002, The Scientist, Inc. All rights reserved.
We welcome your opinion. If you would like to comment on this
article, please write us at
editorial at the-scientist.com
News | Opinions & Letters | Research | Hot Papers
LabConsumer | Profession | About The Scientist | Jobs
Classified | Web Registration | Print Subscriptions | Advertiser
Information
When responding, please attach my original message
_______________________________________________________________________
Eugene Garfield, PhD. email: garfield at codex.cis.upenn.edu
home page: www.eugenegarfield.org
Tel: 215-243-2205 Fax 215-387-1266
President, The Scientist LLC. www.the-scientist.com
Chairman Emeritus, ISI www.isinet.com
Past President, American Society for Information Science and Technology
(ASIS&T) www.asis.org
_______________________________________________________________________
More information about the Sigbioinform-l
mailing list